A new study reports that by 2050, global cancer cases in men are expected to increase by 84%. Cancer deaths for men are expected to increase by 93%. These findings were published in Cancer, a journal of the American Cancer Society (ACS).
The study estimates that from 2022 to 2050:
According to the study, men ages 65 and older could see the largest increase in cancer deaths through 2050, with an estimated increase of 117% in this age group.
“It is important to recognize the increasing frequency of cancer diagnosis as well as the related risk of dying from cancer, especially in more senior individuals, since cancer is more common in older age,” said Petros Grivas, MD, PhD, an American Society of Clinical Oncology (ASCO) expert and Clinical Director of the Genitourinary Cancers Program at University of Washington Medicine.
For men living in the US:
There are many lifestyle factors known to increase cancer risk, including smoking and drinking alcohol. Studies show that men are more likely than women to smoke or drink. They are also more likely to work in jobs that expose them to chemicals known to increase cancer risk.
It is important that men understand their cancer risk. They should get regular health checkups and keep up with recommended cancer screening tests.
“Everyone should establish primary care very early in their lives, whether that means having a single primary care provider or regularly visiting a clinic in the community. It is vitally important to work with your primary care provider so you can receive age-appropriate cancer screening based on the latest scientific evidence and expert guidelines,” said Dr. Grivas. “Genetic counseling can also be critical, especially if there is a family history of cancer or a young age of cancer diagnosis. Additional reasons should be discussed with your provider.”
Men can take steps now to lower their cancer risk. These steps include:
Finally, it is important that men monitor for any physical changes that may or may not be signs of cancer. When cancer is found early, it might be easier to treat successfully.
Dr. Grivas is an Associate Editor on ASCO’s Patient Information Editorial Board.
Developed by the American Society of Clinical Oncology (ASCO).
If this was helpful, donate to help fund patient support services, research, and cancer content updates.